Vital Signs - Vaccines - The Sustainable Blockbuster Business

 

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on March 31, 2011, provides a strategic insight on the vaccines market.

Additionally, a company spotlight is provided for Health Decisions, a CRO that has built a flexible global trial network that offers a structured, technology-backed clinical trial management model that focuses on improving speed and productivity, while minimizing cost and risk for the sponsors.. Reimbursement and regulatory news from the FDA is also provided for week of February 28, 2011.

Table of Contents

Vital Signs - Vaccines - The Sustainable Blockbuster BusinessVital Signs: 31 Mar 2011This week's issue




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Release Date : 30-Oct-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.